0336 (0336) Fair Value & Analysis

Basic Materials · Market cap HK$9.7B

0 0336 0336 · HK

PriceHK$3.01

Fair ValueHK$2.93

Upside-2.7%

Quality59/100

Evidence: Medium Range HK$2.37 – HK$3.50

Fair value as of: Jul 1, 2026

From 9 valuation models · updated today

Share price −15.9% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$2.82 – HK$5.02 · fair‑value band HK$2.37 – HK$3.50 · the HK$3.01 price screens above the HK$2.93 fair value. As of Jul 1, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

0336 (0336) currently trades at HK$3.01, while our model-based Fair Value estimate is HK$2.93 — implying the stock looks roughly 2.7% overvalued today. We read business quality at 59/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 0336 generated revenue of HK$4.3B at a net margin of 33.2%. Revenue grew 27.3% year over year. It earns a return on equity of 10.9%. The balance sheet holds a net cash position of HK$3.4B. Fundamentals as of Jul 1, 2026

Key figures & financial health

Revenue (TTM) HK$4.3B

Revenue growth (YoY) +27.3%

Net margin 33.2%

Return on equity 10.9%

Free cash flow HK$758M FY2026

Operating margin 42.5%

More key figures

EPS (TTM) HK$0.0400

EPS growth (YoY) +34.0%

Net cash HK$3.4B FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 1, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

0336 reported revenue of HK$3.5B in FY2026 versus HK$3.9B in FY2022, a compound −2.7%/yr. Reported net income was −HK$389M in FY2026.

Revenue −2.7%/yr

FY22 HK$3.9B

FY23 HK$3.8B

FY24 HK$3.3B

FY25 HK$3.4B

FY26 HK$3.5B

Net income

FY22 HK$675M

FY23 −HK$1.1B

FY24 HK$234M

FY25 −HK$386M

FY26 −HK$389M

Is 0336 fairly valued? → Check now

Similar stocks

6 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 1, 2026).

Stock	Price	Fair Value	vs Fair Value
Linde plc LIN	$516.71	$221.55	-57%
L'Air Liquide S.A AIQUY	$37.81	$15.56	-59%
Air Products and Chemicals, Inc A1PD34	R$364.32	R$50.60	-86%
Intercontinental Exchange, Inc I1CE34	R$359.64	R$307.76	-14%
Wanhua Chemical Group 600309	¥72.46	¥51.34	-29%
Asian Paints Limited ASIANPAINT	₹2,674	₹739.38	-72%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 0336 (0336) undervalued?

As of Jul 1, 2026, our model estimates a fair value of HK$2.93 versus a price of HK$3.01 — about −3% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 0336?

Our model-based fair value for 0336 is HK$2.93 (as of Jul 1, 2026), built from audited fundamentals. The current price is HK$3.01.

What is the quality score of 0336?

0336 has a Quality Score of 59/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 0336 (0336)?

0336 reported trailing-twelve-month revenue of about HK$4.3B (latest available figure, as of Jul 1, 2026).

What is the net profit margin of 0336?

The net profit margin of 0336 is about 33.2%, meaning it keeps roughly 33.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.